Dr. Ammar Sukari
Claim this profileWayne State University/Karmanos Cancer Institute
Expert in Squamous Cell Carcinoma
Studies Head and Neck Cancers
29 reported clinical trials
45 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Global LeaderStage IV
PD-L1 positive
Stage III
2Head And Neck Cancers
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Ammar Sukari is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Recruiting1 award Phase 1 & 2
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
More about Ammar Sukari
Clinical Trial Related3 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Ammar Sukari has experience with
- Cisplatin
- Pembrolizumab
- Nivolumab
- Intensity-Modulated Radiation Therapy
- Carboplatin
- Image Guided Radiation Therapy
Breakdown of trials Ammar Sukari has run
Squamous Cell Carcinoma
Head and Neck Cancers
Head and Neck Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ammar Sukari specialize in?
Ammar Sukari focuses on Squamous Cell Carcinoma and Head and Neck Cancers. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are PD-L1 positive.
Is Ammar Sukari currently recruiting for clinical trials?
Yes, Ammar Sukari is currently recruiting for 13 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Ammar Sukari has studied deeply?
Yes, Ammar Sukari has studied treatments such as Cisplatin, Pembrolizumab, Nivolumab.
What is the best way to schedule an appointment with Ammar Sukari?
Apply for one of the trials that Ammar Sukari is conducting.
What is the office address of Ammar Sukari?
The office of Ammar Sukari is located at: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Wayne State University/Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.